Now showing items 31-40 of 3501
Molecular aspects of breast cancer resistance to drugs (Review)
(Spandidos Publ, 2015)
Despite continuous advances in the knowledge of breast cancer pathophysiology, this type of neoplasia remains a leading cause of cancer-related death in women worldwide. Carcinogenesis takes a progressive course from ...
From chromosomal abnormalities to the identification of target genes in mouse models of breast cancer
(Elsevier Inc, 2014-06-25)
Cytogenetic studies of breast cancer cells have identified numerous chromosomal imbalances, including gains in human chromosome regions 1q, 4p, 8q, and 20q and losses in regions 1p, 3p, 6q, 11q, 16q, 17p, and 22q. Mouse ...
Molecular Subtypes Of Breast Cancer Are Not Associated With The Clinical Under- Or Overstaging Of Breast CancerSubtipos Moleculares De Câncer De Mama Não Estão Associados Ao Subestadiamento Ou Ao Superestadiamento Do Câncer De Mama
(Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2016)
Differential expression of CD90 and CD14 stem cell markers in malignant breast cancer cell lines
The recently emerged concept of cancer stem cell (CSC) has led to a new hypothesis on the basis for tumor progression. Basically, the CSC theory hypothesizes the presence of a hierarchically organized and relatively rare ...
Analysis of 5382insC (BRCA1) and 6174de1T (BRCA2) mutations in 382 healthy Chilean women with a family history of breast cancer
Breast cancer is the most common malignancy among women. Chilean studies reveal that this cancer presents the third highest mortality rate. A family history of breast cancer is one of the major risk factors for the development ...
Cell culture models and pharmacological perspective for the study of breast cancer markers.
(The International Federation of Clinical Chemistry and Laboratory Medicine, 2019)
Genes and proteins associated with chemotherapeutic resistance in breast cancer
(Science Repository, 2019)
TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families
(BioMed Central, 2014)
Abstract Background Approximately 5-10% of breast cancers are hereditary. Among hereditary syndromes, Hereditary Breast and Ovarian Cancer Syndrome (HBOC) and Li-Fraumeni ...